Report Detail

Medical Industry Global Viral Vector Production (Research-use) Market Growth (Status and Outlook) 2021-2026

  • RnM4354182
  • |
  • 12 November, 2021
  • |
  • Global
  • |
  • 125 Pages
  • |
  • LPI(LP Information)
  • |
  • Medical Industry

According to this latest study, the 2021 growth of Viral Vector Production (Research-use) will have significant change from previous year. By the most conservative estimates of global Viral Vector Production (Research-use) market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ 971.4 million in 2020. Over the next five years the Viral Vector Production (Research-use) market will register a 19.5% CAGR in terms of revenue, the global market size will reach US$ 1981.1 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Viral Vector Production (Research-use) market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Adeno-associated virus (AAV)
Lentivirus
Adenovirus
Retrovirus
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Cell & Gene Therapy Development
Vaccine Development
Biopharmaceutical and Pharmaceutical Discovery
Biomedical Research

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Merck KGaA
Lonza
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
Cobra Biologics Ltd.
Thermo Fisher Scientific
Waisman Biomanufacturing
Genezen
YPOSKESI
Advanced BioScience Laboratories, Inc. (ABL, Inc.)
Novasep Holding S.A.S
Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.)
Vigene Biosciences, Inc.
General Electric Company (GE Healthcare)
CEVEC Pharmaceuticals GmbH
Batavia Biosciences B.V.
Biovion oy
Wuxi AppTec Co., Ltd.
VGXI, Inc.
Catalent Inc.
Miltenyi Biotec GmbH
SIRION Biotech GmbH
Virovek Incorporation
BioNTech IMFS GmbH
VIVEbiotech S.L.
Creative Biogene
Vibalogics GmbH
Takara Bio.
Cell and Gene Therapy Catapult
BlueBird Bio
Addgene, Inc.
Aldevron, L.L.C.
Audentes Therapeutics
BioMarin Pharmaceutical
RegenxBio, Inc.


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Viral Vector Production (Research-use) Market Size 2016-2026
    • 2.1.2 Viral Vector Production (Research-use) Market Size CAGR by Region 2020 VS 2021 VS 2026
  • 2.2 Viral Vector Production (Research-use) Segment by Type
    • 2.2.1 Adeno-associated virus (AAV)
    • 2.2.2 Adeno-associated virus (AAV)
    • 2.2.3 Adenovirus
    • 2.2.4 Retrovirus
    • 2.2.5 Others
  • 2.3 Viral Vector Production (Research-use) Market Size by Type
    • 2.3.1 Global Viral Vector Production (Research-use) Market Size CAGR by Type
    • 2.3.2 Global Viral Vector Production (Research-use) Market Size Market Share by Type (2016-2021)
  • 2.4 Viral Vector Production (Research-use) Segment by Application
    • 2.4.1 Cell & Gene Therapy Development
    • 2.4.2 Vaccine Development
    • 2.4.3 Biopharmaceutical and Pharmaceutical Discovery
    • 2.4.4 Biomedical Research
  • 2.5 Viral Vector Production (Research-use) Market Size by Application
    • 2.5.1 Global Viral Vector Production (Research-use) Market Size CAGR by Application
    • 2.5.2 Global Viral Vector Production (Research-use) Market Size Market Share by Application (2016-2021)

3 Viral Vector Production (Research-use) Market Size by Players

  • 3.1 Viral Vector Production (Research-use) Market Size Market Share by Players
    • 3.1.1 Global Viral Vector Production (Research-use) Revenue by Players (2019-2021E)
    • 3.1.2 Global Viral Vector Production (Research-use) Revenue Market Share by Players (2019-2021E)
  • 3.2 Global Viral Vector Production (Research-use) Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Viral Vector Production (Research-use) by Regions

  • 4.1 Viral Vector Production (Research-use) Market Size by Regions (2016-2021)
  • 4.2 Americas Viral Vector Production (Research-use) Market Size Growth (2016-2021)
  • 4.3 APAC Viral Vector Production (Research-use) Market Size Growth (2016-2021)
  • 4.4 Europe Viral Vector Production (Research-use) Market Size Growth (2016-2021)
  • 4.5 Middle East & Africa Viral Vector Production (Research-use) Market Size Growth (2016-2021)

5 Americas

  • 5.1 Americas Viral Vector Production (Research-use) Market Size by Country (2016-2021)
  • 5.2 Americas Viral Vector Production (Research-use) Market Size by Type (2016-2021)
  • 5.3 Americas Viral Vector Production (Research-use) Market Size by Application (2016-2021)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Viral Vector Production (Research-use) Market Size by Region (2016-2021)
  • 6.2 APAC Viral Vector Production (Research-use) Market Size by Type (2016-2021)
  • 6.3 APAC Viral Vector Production (Research-use) Market Size by Application (2016-2021)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Viral Vector Production (Research-use) by Country (2016-2021)
  • 7.2 Europe Viral Vector Production (Research-use) Market Size by Type (2016-2021)
  • 7.3 Europe Viral Vector Production (Research-use) Market Size by Application (2016-2021)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Viral Vector Production (Research-use) by Region (2016-2021)
  • 8.2 Middle East & Africa Viral Vector Production (Research-use) Market Size by Type (2016-2021)
  • 8.3 Middle East & Africa Viral Vector Production (Research-use) Market Size by Application (2016-2021)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers and Impact
    • 9.1.1 Growing Demand from Key Regions
    • 9.1.2 Growing Demand from Key Applications and Potential Industries
  • 9.2 Market Challenges and Impact
  • 9.3 Market Trends

10 Global Viral Vector Production (Research-use) Market Forecast

  • 10.1 Global Viral Vector Production (Research-use) Forecast by Regions (2021-2026)
    • 10.1.1 Global Viral Vector Production (Research-use) Forecast by Regions (2021-2026)
    • 10.1.2 Americas Viral Vector Production (Research-use) Forecast
    • 10.1.3 APAC Viral Vector Production (Research-use) Forecast
    • 10.1.4 Europe Viral Vector Production (Research-use) Forecast
    • 10.1.5 Middle East & Africa Viral Vector Production (Research-use) Forecast
  • 10.2 Americas Viral Vector Production (Research-use) Forecast by Countries (2021-2026)
    • 10.2.1 United States Viral Vector Production (Research-use) Market Forecast
    • 10.2.2 Canada Viral Vector Production (Research-use) Market Forecast
    • 10.2.3 Mexico Viral Vector Production (Research-use) Market Forecast
    • 10.2.4 Brazil Viral Vector Production (Research-use) Market Forecast
  • 10.3 APAC Viral Vector Production (Research-use) Forecast by Region (2021-2026)
    • 10.3.1 China Viral Vector Production (Research-use) Market Forecast
    • 10.3.2 Japan Viral Vector Production (Research-use) Market Forecast
    • 10.3.3 Korea Viral Vector Production (Research-use) Market Forecast
    • 10.3.4 Southeast Asia Viral Vector Production (Research-use) Market Forecast
    • 10.3.5 India Viral Vector Production (Research-use) Market Forecast
    • 10.3.6 Australia Viral Vector Production (Research-use) Market Forecast
  • 10.4 Europe Viral Vector Production (Research-use) Forecast by Country (2021-2026)
    • 10.4.1 Germany Viral Vector Production (Research-use) Market Forecast
    • 10.4.2 France Viral Vector Production (Research-use) Market Forecast
    • 10.4.3 UK Viral Vector Production (Research-use) Market Forecast
    • 10.4.4 Italy Viral Vector Production (Research-use) Market Forecast
    • 10.4.5 Russia Viral Vector Production (Research-use) Market Forecast
  • 10.5 Middle East & Africa Viral Vector Production (Research-use) Forecast by Region (2021-2026)
    • 10.5.1 Egypt Viral Vector Production (Research-use) Market Forecast
    • 10.5.2 South Africa Viral Vector Production (Research-use) Market Forecast
    • 10.5.3 Israel Viral Vector Production (Research-use) Market Forecast
    • 10.5.4 Turkey Viral Vector Production (Research-use) Market Forecast
    • 10.5.5 GCC Countries Viral Vector Production (Research-use) Market Forecast
  • 10.6 Global Viral Vector Production (Research-use) Forecast by Type (2021-2026)
  • 10.7 Global Viral Vector Production (Research-use) Forecast by Application (2021-2026)

11 Key Players Analysis

  • 11.1 Merck KGaA
    • 11.1.1 Merck KGaA Company Information
    • 11.1.2 Merck KGaA Viral Vector Production (Research-use) Product Offered
    • 11.1.3 Merck KGaA Viral Vector Production (Research-use) Revenue, Gross Margin and Market Share (2019-2021)
    • 11.1.4 Merck KGaA Main Business Overview
    • 11.1.5 Merck KGaA Latest Developments
  • 11.2 Lonza
    • 11.2.1 Lonza Company Information
    • 11.2.2 Lonza Viral Vector Production (Research-use) Product Offered
    • 11.2.3 Lonza Viral Vector Production (Research-use) Revenue, Gross Margin and Market Share (2019-2021)
    • 11.2.4 Lonza Main Business Overview
    • 11.2.5 Lonza Latest Developments
  • 11.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
    • 11.3.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Information
    • 11.3.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) Product Offered
    • 11.3.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) Revenue, Gross Margin and Market Share (2019-2021)
    • 11.3.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Main Business Overview
    • 11.3.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Latest Developments
  • 11.4 Cobra Biologics Ltd.
    • 11.4.1 Cobra Biologics Ltd. Company Information
    • 11.4.2 Cobra Biologics Ltd. Viral Vector Production (Research-use) Product Offered
    • 11.4.3 Cobra Biologics Ltd. Viral Vector Production (Research-use) Revenue, Gross Margin and Market Share (2019-2021)
    • 11.4.4 Cobra Biologics Ltd. Main Business Overview
    • 11.4.5 Cobra Biologics Ltd. Latest Developments
  • 11.5 Thermo Fisher Scientific
    • 11.5.1 Thermo Fisher Scientific Company Information
    • 11.5.2 Thermo Fisher Scientific Viral Vector Production (Research-use) Product Offered
    • 11.5.3 Thermo Fisher Scientific Viral Vector Production (Research-use) Revenue, Gross Margin and Market Share (2019-2021)
    • 11.5.4 Thermo Fisher Scientific Main Business Overview
    • 11.5.5 Thermo Fisher Scientific Latest Developments
  • 11.6 Waisman Biomanufacturing
    • 11.6.1 Waisman Biomanufacturing Company Information
    • 11.6.2 Waisman Biomanufacturing Viral Vector Production (Research-use) Product Offered
    • 11.6.3 Waisman Biomanufacturing Viral Vector Production (Research-use) Revenue, Gross Margin and Market Share (2019-2021)
    • 11.6.4 Waisman Biomanufacturing Main Business Overview
    • 11.6.5 Waisman Biomanufacturing Latest Developments
  • 11.7 Genezen
    • 11.7.1 Genezen Company Information
    • 11.7.2 Genezen Viral Vector Production (Research-use) Product Offered
    • 11.7.3 Genezen Viral Vector Production (Research-use) Revenue, Gross Margin and Market Share (2019-2021)
    • 11.7.4 Genezen Main Business Overview
    • 11.7.5 Genezen Latest Developments
  • 11.8 YPOSKESI
    • 11.8.1 YPOSKESI Company Information

Summary:
Get latest Market Research Reports on Viral Vector Production (Research-use). Industry analysis & Market Report on Viral Vector Production (Research-use) is a syndicated market report, published as Global Viral Vector Production (Research-use) Market Growth (Status and Outlook) 2021-2026. It is complete Research Study and Industry Analysis of Viral Vector Production (Research-use) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,500.00
$7,000.00
2,796.50
5,593.00
3,265.50
6,531.00
544,425.00
1,088,850.00
291,655.00
583,310.00
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report